Kennedy Capital Management, Inc. Harpoon Therapeutics, Inc. Transaction History

Kennedy Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.65 - $1.37 $239,488 - $504,768	368,444 Added 228.15%	529,934 $392,000
Q4 2022 Feb 14, 2023	SELL	$0.6 - $1.41 $77,031 - $181,022	-128,385 Reduced 44.29%	161,490 $117,000
Q3 2022 Nov 14, 2022	BUY	$0.94 - $2.56 $167,875 - $457,192	178,591 Added 160.48%	289,875 $281,000
Q2 2022 Aug 10, 2022	SELL	$1.78 - $5.02 $1,904 - $5,371	-1,070 Reduced 0.95%	111,284 $213,000
Q1 2022 May 16, 2022	SELL	$3.54 - $8.08 $61,638 - $140,688	-17,412 Reduced 13.42%	112,354 $558,000
Q4 2021 Feb 14, 2022	BUY	$5.69 - $7.83 $738,368 - $1.02 Million	129,766 New	129,766 $980,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.